Fundraising FoxRecolony
1 known investors
Find your way into Recolony
Sign up to find every way you can get introduced to Recolony
- Your email: who you already know at Recolony, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Recolony team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Adularia (Recolony) develops cancer immunotherapies based on microbiome research, using a microbial metabolite mechanism that activates tumor-residing macrophages to trigger an anti-tumor immune response. The company designs an optimized, tumor-targeted immunotherapy molecule using multi-omics and AI-driven molecule design.</parameter> <parameter name="founders">[{"full_name": "Ana Montalban-Arques", "title": "CEO & Co-Founder"}, {"full_name": "Philipp Busenhart", "title": "COO & Co-Founder"}, {"full_name": "Egl\u0117 Katkevi\u010di\u016bt\u0117", "title": "CSO & Co-Founder"}, {"full_name": "David Seeberger", "title": "CFO"}]
Investors · 1
How we know: Kickfund's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Recolony do?
- Adularia (Recolony) develops cancer immunotherapies based on microbiome research, using a microbial metabolite mechanism that activates tumor-residing macrophages to trigger an anti-tumor immune response. The company designs an optimized, tumor-targeted immunotherapy molecule using multi-omics and AI-driven molecule design.</parameter> <parameter name="founders">[{"full_name": "Ana Montalban-Arques", "title": "CEO & Co-Founder"}, {"full_name": "Philipp Busenhart", "title": "COO & Co-Founder"}, {"full_name": "Egl\u0117 Katkevi\u010di\u016bt\u0117", "title": "CSO & Co-Founder"}, {"full_name": "David Seeberger", "title": "CFO"}]
- Who are Recolony's investors?
- Recolony's investors include Kickfund.